Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Staar Surgical (STAA)
NASDAQ:STAA
Holding STAA?
Track your performance easily
STAA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.13 - $52.68
Previous CloseN/A
Volume326.32K
Average Volume (3M)653.16K
Market Cap
$1.20B
Enterprise Value$1.66B
Total Cash (Recent Filing)$14.00M
Total Debt (Recent Filing)$1.34M
Price to Earnings (P/E)55.8
Beta1.12
Next Earnings
Feb 19, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.44
Shares Outstanding49,275,875
10 Day Avg. Volume679,385
30 Day Avg. Volume653,164
Standard Deviation0.18
R-Squared0.03
Alpha0.00194
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.53
Price to Cash Flow (P/CF)78.90
P/FCF Ratio0.00
Enterprise Value/Market Cap1.37
Enterprise Value/Revenue4.85
Enterprise Value/Gross Profit6.55
Enterprise Value/Ebitda65.20
Forecast
1Y Price Target
$35.50Price Target Upside46.75% Upside
Rating ConsensusHold
Number of Analyst Covering8
Staar Surgical News
PremiumCompany Announcements
Staar Surgical to Announce 2024 Financial Results
PremiumCompany Announcements
STAAR Surgical Posts Strong Q3 2024 Financial Results
PremiumCompany Announcements
Staar Surgical Achieves 10% Sales Growth, Income DoublesBulls Say, Bears Say
Bulls Say
Financial PerformanceSTAA showed better than expected operating margin leverage.
Market ExpansionSTAAR's lens will be seen as a premium option in the China market.
Revenue GrowthSTAA's 3Q24 revenue beat consensus.
Bears Say
Competitive PressureThe approval of Eyebright Medical's phakic IOL in China increases competition in STAA's largest market, potentially impacting its market position.
Financial GuidanceManagement reduced growth expectations for both China and the US, indicating a challenging market environment.
Market UncertaintyMacroeconomic uncertainty and the elective nature of refractive procedures have dampened the global refractive market, with particular concern about China.
---
Ownership Overview
44.52% Insiders
19.04% Mutual Funds
0.11% Other Institutional Investors
7.27% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STAA FAQ
What was Staar Surgical’s price range in the past 12 months?
Staar Surgical lowest stock price was $21.13 and its highest was $52.68 in the past 12 months.
What is Staar Surgical’s market cap?
Staar Surgical’s market cap is $1.20B.
When is Staar Surgical’s upcoming earnings report date?
Staar Surgical’s upcoming earnings report date is Feb 19, 2025 which is in 19 days.
How were Staar Surgical’s earnings last quarter?
Staar Surgical released its earnings results on Oct 30, 2024. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.08.
Is Staar Surgical overvalued?
According to Wall Street analysts Staar Surgical’s price is currently Undervalued.
Does Staar Surgical pay dividends?
Staar Surgical does not currently pay dividends.
What is Staar Surgical’s EPS estimate?
Staar Surgical’s EPS estimate is -0.04.
How many shares outstanding does Staar Surgical have?
Staar Surgical has 49,275,875 shares outstanding.
What happened to Staar Surgical’s price movement after its last earnings report?
Staar Surgical reported an EPS of $0.26 in its last earnings report, beating expectations of $0.18. Following the earnings report the stock price went down -1.695%.
Which hedge fund is a major shareholder of Staar Surgical?
Currently, no hedge funds are holding shares in STAA
---
Staar Surgical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$35.50 (46.75% Upside)
$35.50 (46.75% Upside)
Blogger Sentiment
Bullish
STAA Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 28.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.4%
Last 30 Days ▲ 18.5%
Last 30 Days ▲ 18.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.50%
12-Months-Change
Fundamentals
Return on Equity
5.40%
Trailing 12-Months
Asset Growth
14.01%
Trailing 12-Months
Company Description
Staar Surgical
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
---
STAA Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
STAAR Surgical demonstrated strong global sales growth, particularly in the U.S., EMEA, Japan, and South Korea, with strategic investments in training and infrastructure. However, challenges in China and a decrease in gross margins due to production issues were notable concerns. Overall, the company shows resilience and a positive growth trajectory.Read More>---
STAA Stock 12 Month Forecast
Average Price Target
$35.50
▲(46.75% Upside)
Technical Analysis
Baxter International
―
Boston Scientific
―
Edwards Lifesciences
―
ICU Medical
―
Zimmer Biomet Holdings
―
Best Analysts Covering STAA
1 Year
1 Year Success Rate
4/12 ratings generated profit
1 Year Average Return
-4.41%
reiterated a buy rating 24 days ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -4.41% per trade.
---